Soligenix

SNGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.380 M

$0.39 +3.50%

Close of 22 Sept 2026

Revenue

$119.4K

#3585 by revenue

Earnings

-$11.1M

Loss-making

Shares outstanding

21,765,479

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#442ImunonIMNN$8.47M
#443ExicureXCUR$8.44M
#444SoligenixSNGX$8.38M
#445Ensysce BiosciencesENSC$8.35M
#446Traws PharmaTRAW$7.68M

What if Soligenix were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,389,079

Per share 3,607,998× higher

Bitcoin $1.74T

$80,019.15

Per share 207,842× higher

Nvidia $5.52T

$253,418.14

Per share 658,229× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Soligenix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.